Lancaster General Hospital
Clinical trials sponsored by Lancaster General Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood thinner users with head injuries may benefit from platelet transfusions Results expected Dec 2026 (estimated)
-
Breathing therapy tested for heart failure – trial stopped early
Symptom relief Stopped earlyThis study tested whether a special breathing exercise program could help people with systolic heart failure walk farther and feel better. The trial planned to enroll 65 adults with moderate heart failure, but it was terminated early. Participants would have been assigned to eith…
Sponsor: Lancaster General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Concussion headache drug trial stalls early
Symptom relief Stopped earlyThis study tested whether nortriptyline, a common antidepressant, could ease headaches after a concussion better than a placebo. It included teens aged 13-21 with recent head trauma. The trial was stopped early after enrolling only 8 people, so the results are not reliable.
Phase 4 • Sponsor: Lancaster General Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 16:53 UTC
-
MRI safety for broken heart leads: small study ends early
Knowledge-focused Stopped earlyThis study aimed to see if MRI scans are safe for people with broken or unused wires (leads) from pacemakers or defibrillators. It enrolled 18 participants and monitored for side effects like chest pain or heart rhythm problems. The study was terminated early, so the findings are…
Sponsor: Lancaster General Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:23 UTC